OUR 2025 SPONSORS

Diasorin

Diasorin is committed to improving healthcare by providing an unparalleled portfolio of exclusive, high-quality immunoassays and fully automated chemiluminescence analysers that deliver standardised and unbiased results. As easy-to-use as they are reliable, we allow laboratory and healthcare professionals to streamline their diagnostic pathways while ensuring complete harmonisation between urgent, specialty and routine tests. 

Roche

For more than 65 years, Roche Diagnostics Australia has been providing healthcare solutions to Australians. Our team of almost 200 people across 5 locations collectively work towards our shared goal through our market leading innovative platforms, lifesaving assays and workflow enhancing solutions. Today, we are committed to our purpose of providing better healthcare outcomes for everyone in Australia. 

Abbott

Abbott is a global leader in in vitro diagnostics with one of the broadest portfolios of businesses spanning nearly every segment – point of care, immunoassay, clinical chemistry, hematology, blood screening, molecular, and digital health solutions. Abbott’s life-changing tests and diagnostic tools provide accurate, timely information to better manage health. We’re empowering smarter medical and economic decision making to help transform the way people manage their health at all stages of life.

Connect with your Abbott Representative or visit corelaboratory.abbott or molecular.abbott

Hologic

Hologic’s purpose is to empower people to live healthier lives everywhere, every day. This is achieved by bringing The Science of Sure® to life. As a leading innovator and champion for women’s health, Hologic helps healthcare professionals around the world diagnose and treat their patients with precision, certainty, and confidence. With ground-breaking technology at the core, Hologic innovations across breast & skeletal health, diagnostic solutions, and GYN surgical solutions are designed to achieve exceptional clinical results, making it possible to detect, diagnose and treat illnesses and other health conditions earlier and more effectively.

Cepheid

Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing.

Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings.

For more information, visit cepheid.com

Southern Cross Diagnostics

Southern Cross Diagnostics excels in microbiology, autoimmune and infectious disease diagnostics, providing advanced serology and molecular testing solutions. The extensive range includes specialised laboratory equipment and diagnostic test kits, sourced through global partnerships. We are dedicated to offering innovative specialty diagnostic technologies, tailored to meet the unique requirements of medical laboratories.

Integrated Sciences

Integrated Sciences specialises in the sale and support of Clinical Diagnostics, Molecular Diagnostics and Research products in Australia and New Zealand. Our success has stemmed from our ability to understand our customers’ needs and partnering with innovative and reliable International suppliers, including Seegene, Osang Healthcare, Liofilchem, AESKU.GROUP, Biodiagnostics and Agilent Genomics. Our company motto "Our Strategy is Support" exemplifies our focus and recognises the support and skills of our staff in enabling our success.

Bio-Rad

Genetic Signatures

Genetic Signatures is a global molecular diagnostics company specialising in the detection of infectious diseases. The Company's proprietary 3base® technology enhances flexibility by enabling uniform sample processing across all specimen types and simplifying the genetic complexity involved in pathogen detection. This is particularly advantageous for identifying subtypes and emerging variants. The streamlined, automated workflow supports simplified, multiplexed real-time PCR assays capable of detecting numerous pathogens from a single sample, without compromising throughput. EasyScreen™ assays are integrated with automated systems to deliver a seamless, end-to-end diagnostic solution. Genetic Signatures’ unique solutions support laboratories to improve diagnostic workflow and efficiencies, reduce costs, improve patient management, and disease surveillance. Visit www.geneticsignatures.com to learn more.